Newsbenzinga
Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
· Published
Article summary
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 12.55% on an annualized basis producing an average annual return of 21.73%. Currently, Regeneron Pharmaceuticals has a market
An excerpt from the original article.
Comments —
Loading comments…